Hypofractionated LocoRegional Radiotherapy in Breast Cancer

Clinical trial NCT04228991 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04228991
Sponsor: Ontario Clinical Oncology Group (OCOG)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Neoplasms Radiotherapy Lymphedema

Start date: 2021-02-10
Primary completion: 2028-07-01
Enrollment: 588

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.